Leading the Way to Health Equity
Researchers from a broad range of fields at the University of California San Diego are making waves as they push the boundaries of science and medicine to develop...
5 minutes ago - San Diego Biotechnology
Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas
A preclinical central nervous system biotech is in the works in La Jolla, CA, and the drug developer has reeled in capital from a syndicate of investors, Endpoints News has...
1 hour ago - San Diego Biotechnology
Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
CARLSBAD, Calif.--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TrueMark Infectious Disease Research Panels designed to...
2 hours ago - San Diego Biotechnology
Calidi Biotherapeutics to Present at the 7th Annual Oncolytic Virotherapy Summit
LA JOLLA, Calif.--Calidi Biotherapeutics to Present at the 7th Annual Oncolytic Virotherapy Summit
2 hours ago - San Diego Biotechnology
San Diego's Avalon BioVentures raises $135M to invest in biotech, health care startups
The biotech team at Avalon Ventures has spun out into a new venture capital organization focused solely on backing early stage life science firms
2 hours ago - San Diego Biotechnology - 2 articles
Rescue of an enterotropic Newcastle disease virus strain ZM10 from cloned cDNA and stable expressing an inserted foreign gene
Newcastle disease virus strain ZM10, a typical enterotropic avirulent vaccine strain, has been widely used in China for chickens against Newcastle disease. To elucidate its...
2 hours ago - BMC Biotechnology
Extended-release of doxorubicin through green surface modification of gold nanoparticles: in vitro and in ovo assessment
In the present study, a green surface modification of gold nanoparticles using chondroitin sulfate and chitosan to deliver an extended-release of doxorubicin was proposed...
2 hours ago - Chemistry Central
Scientist-Immuno-Oncology Flow Cytometry - Novartis - Carlsbad, CA
Navigate Biopharma, a fully owned subsidiary of Novartis, provides assay development, clinical trial testing, and companion diagnostics services to companies...
3 hours ago - San Diego Biotechnology
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
LA JOLLA, Calif.--- $EQ-Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders...
3 hours ago - San Diego Biotechnology
A new Vega enters the galaxy with bleeding disorder antibody set for 2023 trial
Biotech incubator Star Therapeutics has launched another galaxy-themed drug developer, which next year will test a new antibody in a bleeding disorder currently treated by...
3 hours ago - San Diego Biotechnology
Free Registration
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas
A preclinical central nervous system biotech is in the works in La Jolla, CA, and the drug developer has reeled in capital from a syndicate of investors, Endpoints News has...
Calidi Biotherapeutics to Present at the 7th Annual Oncolytic Virotherapy Summit
LA JOLLA, Calif.--Calidi Biotherapeutics to Present at the 7th Annual Oncolytic Virotherapy Summit
Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
CARLSBAD, Calif.--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TrueMark Infectious Disease Research Panels designed to...
Rescue of an enterotropic Newcastle disease virus strain ZM10 from cloned...
Newcastle disease virus strain ZM10, a typical enterotropic avirulent vaccine strain, has been widely used in China for chickens against Newcastle disease. To elucidate its...
Extended-release of doxorubicin through green surface modification of gold...
In the present study, a green surface modification of gold nanoparticles using chondroitin sulfate and chitosan to deliver an extended-release of doxorubicin was proposed...
Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY...
SAN DIEGO--Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas...
A new Vega enters the galaxy with bleeding disorder antibody set for 2023 trial
Biotech incubator Star Therapeutics has launched another galaxy-themed drug developer, which next year will test a new antibody in a bleeding disorder currently treated by...
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset...
LA JOLLA, Calif.--- $EQ-Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders...
Scientist-Immuno-Oncology Flow Cytometry - Novartis - Carlsbad, CA
Navigate Biopharma, a fully owned subsidiary of Novartis, provides assay development, clinical trial testing, and companion diagnostics services to companies...
As FDA door shuts on its PI3K, MEI Pharma throws in the towel, lays off staff
Having steered a PI3K inhibitor from preclinical studies all the way to Phase II, San Diego's MEI Pharma is all but washing its hands of the drug as the FDA raises the bar on...